| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 31-Dec-08 | | Total Revenue | 110,706 | 82,576 | 59,038 | 112,736 | | Cost of Revenue | 65,929 | 58,846 | 54,020 | 80,494 | | | Gross Profit | 44,777 | 23,730 | 5,018 | 32,242 | | | Operating Expenses | | Research Development | 8,575 | 7,843 | 8,904 | 8,939 | | Selling General and Administrative | 29,175 | 25,685 | 29,721 | 31,731 | | Non Recurring | 2,368 | 5,452 | 4,634 | 101,080 | | Others | 4,723 | 4,931 | 4,981 | 5,088 | | | | Total Operating Expenses | 44,841 | 43,911 | 48,240 | 146,838 | | | | Operating Income or Loss | (64) | (20,181) | (43,222) | (114,596) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4,115) | (1,536) | 5,222 | (11,867) | | Earnings Before Interest And Taxes | (4,179) | (21,717) | (38,000) | (126,463) | | Interest Expense | 2,680 | 2,578 | 1,847 | 2,132 | | Income Before Tax | (6,859) | (24,295) | (39,847) | (128,595) | | Income Tax Expense | 624 | (2,252) | (2,598) | 2,889 | | Minority Interest | 6 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (7,608) | (22,492) | (37,745) | (131,718) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| (80) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (7,608) | (22,492) | (37,745) | (131,798) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($7,608) | ($22,492) | ($37,745) | ($131,798) |
|
1.48% Nasdaq 
Income Statement
